Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
November 6, 2019
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
Giulia Amico, Chiara Brandas, Oscar Moran, et al.
Current Opinion in Immunology
|
December 18, 2022
HyperIgE in hypomorphic recombination-activating gene defects
Maria Carmina Castiello, Chiara Brandas, Valentina Capo, et al.
Biomolecules
|
October 23, 2021
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
Chiara Brandas, Alessandra Ludovico, Alice Parodi, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 23, 2023
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein
Debora Baroni, Naomi Scarano, Alessandra Ludovico, et al.
Cell Reports. Medicine
|
November 13, 2024
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
Lucrezia Della Volpe, Federico Midena, Roberta Vacca, et al.
Nature Cell Biology
|
April 9, 2024
CD32 captures committed haemogenic endothelial cells during human embryonic development
Rebecca Scarfò, Lauren N Randolph, Monah Abou Alezz, et al.
Elife
|
March 5, 2019
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing
Francesca Angiolini, Elisa Belloni, Marco Giordano, et al.
Science Translational Medicine
|
February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
Maria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
November 6, 2019
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
Giulia Amico, Chiara Brandas, Oscar Moran, et al.
Current Opinion in Immunology
|
December 18, 2022
HyperIgE in hypomorphic recombination-activating gene defects
Maria Carmina Castiello, Chiara Brandas, Valentina Capo, et al.
Biomolecules
|
October 23, 2021
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
Chiara Brandas, Alessandra Ludovico, Alice Parodi, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 23, 2023
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein
Debora Baroni, Naomi Scarano, Alessandra Ludovico, et al.
Cell Reports. Medicine
|
November 13, 2024
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
Lucrezia Della Volpe, Federico Midena, Roberta Vacca, et al.
Nature Cell Biology
|
April 9, 2024
CD32 captures committed haemogenic endothelial cells during human embryonic development
Rebecca Scarfò, Lauren N Randolph, Monah Abou Alezz, et al.
Elife
|
March 5, 2019
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing
Francesca Angiolini, Elisa Belloni, Marco Giordano, et al.
Science Translational Medicine
|
February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
Maria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Page
of 1